Functional analysis of AML1 gene in normal hematopoietic cells and leukemia cells
正常造血细胞和白血病细胞中AML1基因的功能分析
基本信息
- 批准号:07457229
- 负责人:
- 金额:$ 4.48万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The AML1 gene on chromosome 21 is disrupted in the (8 ; 21) (q22 ; q22) and (3 ; 21) (q26 ; q22) translocations associated with myelogenous leukemias and encodes a transcription factor. From AML1 gene, two representative forms of proteins, AML1a and AML1b, are produced by an alternative splicing. Overexpressed AML1a totally suppresses granulocytic differentiation and stimulates cell proliferation in 32Dc13 murine myeloid cells treated with granulocyte colony-stimulating factor. These effects by AML1a were canceled by the concomitant overexpression of AML1b. Such biological phenomena could be explained by our observations that AML1a, which solely has no effects as a transcriptional regulator, dominantly suppresses transcriptional activation by AML1b, and that AML1a exhibits the higher affinity for DNA-binding than AML1b. These antagonistic actions could be important for leukemogenesis and/or myeloid cell differentiation.We also investigate the regulatory mechanisms of AML1 functions through signal transduction pathways. AML1 is phosphorylated in vivo on two serine residues within the proline-, serine- and threonine-rich region, with dependence on the activation of extracellular signal-regulated kinase (ERK). These in vivo phosphorylation sites of AML1 were directly phosphorylated in vitro by ERK.Although alterations in the DNA-binding affinity were not observed between wild AML1 and non-phosphorylated mutants, we have shown that ERK-dependent phosphorylation potentiates the transactivation ability of AML1. Furthermore the phosphorylation site-mutations reduced the transforming capacity of AML1 in fibroblast cells. These data suggest that AML1 functions are regulated by ERK which is activated by cytokine or growth facotr-stimuli. This study would give important clues to clarify unidentified facets of regulatory mechanisms of AML1 function.
21 号染色体上的 AML1 基因在与骨髓性白血病相关的 (8 ; 21) (q22 ; q22) 和 (3 ; 21) (q26 ; q22) 易位中被破坏,并编码转录因子。 AML1 基因通过选择性剪接产生两种代表性的蛋白质形式:AML1a 和 AML1b。在用粒细胞集落刺激因子处理的 32Dc13 小鼠骨髓细胞中,过表达的 AML1a 完全抑制粒细胞分化并刺激细胞增殖。 AML1a 的这些影响被伴随的 AML1b 过度表达所抵消。这种生物学现象可以通过我们的观察来解释,即 AML1a 本身不具有转录调节作用,但主要抑制 AML1b 的转录激活,并且 AML1a 比 AML1b 表现出更高的 DNA 结合亲和力。这些拮抗作用对于白血病发生和/或骨髓细胞分化可能很重要。我们还通过信号转导途径研究了 AML1 功能的调节机制。 AML1 在体内在富含脯氨酸、丝氨酸和苏氨酸的区域内的两个丝氨酸残基上被磷酸化,依赖于细胞外信号调节激酶 (ERK) 的激活。 AML1 的这些体内磷酸化位点在体外被 ERK 直接磷酸化。尽管在野生 AML1 和非磷酸化突变体之间没有观察到 DNA 结合亲和力的变化,但我们已经证明 ERK 依赖性磷酸化增强了 AML1 的反式激活能力。此外,磷酸化位点突变降低了成纤维细胞中 AML1 的转化能力。这些数据表明 AML1 功能受细胞因子或生长因子刺激激活的 ERK 调节。这项研究将为澄清 AML1 功能调节机制的未识别方面提供重要线索。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakamoto T: "Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase." J.Biol.Chem.271. 8959-8965 (1996)
Nakamoto T:“p130Cas 的 C 末端区域与 Src 激酶的 SH2 和 SH3 结构域直接结合。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanaka T,Kurokawa M,Ueki K,Tanaka K,Imai Y,Mitani K,Yzaki Y,Shibata Y,Kadowaki T,Hirai H.: "The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation abilit
Tanaka T,Kurokawa M,Ueki K,Tanaka K,Imai Y,Mitani K,Yzaki Y,Shibata Y,Kadowaki T,Hirai H.:“细胞外信号调节激酶途径磷酸化 AML1,一种急性髓系白血病基因产物,并且
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kurokawa M: "Overexpression of the human AML1b proto-oncoprotein leads to neoplastic transformation of NIH3T3 cells." Oncogene. 12. 883-892 (1996)
Kurokawa M:“人类 AML1b 原癌蛋白的过度表达会导致 NIH3T3 细胞的肿瘤转化。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yamagata T,Nishida J,Tanaka T,Sakai R,Mitani K,Yoshida M,Taniguchi T,Yazaki Y,Hirai H.: "Molecular cloning of a novel IRF family transcription factor, ICSAT/Pip/LSIRF,that negatively regulated the activity of the interferon-regulated genes" Mol.Cell.Biol.
Yamagata T,Nishida J,Tanaka T,Sakai R,Mitani K,Yoshida M,Taniguchi T,Yazaki Y,Hirai H.:“新型 IRF 家族转录因子 ICSAT/Pip/LSIRF 的分子克隆,该因子负向调节活性
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kurokawa M,Tanaka T,Tanaka K,Hirano N,Ogawa S,Mitani K,Yazaki Y,Hirai H.: "A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA-binding activity and the transforming activity on fibroblasts" J.Biol.Chem.271. 16870-16876
Kurokawa M、Tanaka T、Tanaka K、Hirano N、Okawa S、Mitani K、Yazaki Y、Hirai H.:“AML1 的 runt 同源结构域中的保守半胱氨酸残基对于 DNA 结合活性和转化活性是必需的。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HIRAI Hisamaru其他文献
HIRAI Hisamaru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HIRAI Hisamaru', 18)}}的其他基金
Analyses of Maltipotential Functions of a Novel Signaling Molecule, Cas
新型信号分子 Cas 的多电位功能分析
- 批准号:
11694250 - 财政年份:1999
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
Practical development of a novel method for hematopoietic stem cell expansion
造血干细胞扩增新方法的实际开发
- 批准号:
09357010 - 财政年份:1997
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Analyses of a Novel Signaling Molecule, Cas
新型信号分子 Cas 的分析
- 批准号:
09044271 - 财政年份:1997
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for international Scientific Research
Analysis of molecular mechanisms of leukemia development
白血病发生发展的分子机制分析
- 批准号:
09307021 - 财政年份:1997
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Analysis of Molecular Mechanism of Blastic Crisis in Chronic Myelocytic Leukemia
慢性粒细胞白血病原始细胞危象的分子机制分析
- 批准号:
07042002 - 财政年份:1995
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for international Scientific Research
Molecular analysis of leukemias with chromosomal translocation and its application for clinical Diagnosis
染色体易位白血病的分子分析及其在临床诊断中的应用
- 批准号:
05454328 - 财政年份:1993
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Molecular Diagnosis of Human Leukemias
人类白血病的分子诊断
- 批准号:
04253208 - 财政年份:1992
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Development and clinical application of molecular diagnosis in leukemias
白血病分子诊断技术的发展及临床应用
- 批准号:
04557133 - 财政年份:1992
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Analysis of signal transduction mechanism through a novel tyrosine kinase receptor
新型酪氨酸激酶受体信号转导机制分析
- 批准号:
03454521 - 财政年份:1991
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Elucidation of transcription-coupled chromosomal translocation pathways between gene loci
基因位点之间转录偶联染色体易位途径的阐明
- 批准号:
20K21536 - 财政年份:2020
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Chromosomal translocation and the involvement of DNA repair system in sarcoma.
肉瘤中染色体易位和 DNA 修复系统的参与。
- 批准号:
18K09110 - 财政年份:2018
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Leukemic development through chromosomal translocation with super-enhancer exchange
通过染色体易位和超级增强子交换导致白血病的发展
- 批准号:
18K16090 - 财政年份:2018
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The elucidation of molecular mechanism of chromosomal translocation in prostate cancer and application to new treatment
前列腺癌染色体易位分子机制的阐明及其在新治疗中的应用
- 批准号:
17K16787 - 财政年份:2017
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Therapeutic option for ALK-positive lung cancer targeting the chromosomal translocation based on chromoslipsis
基于染色体滑移的 ALK 阳性肺癌靶向染色体易位的治疗选择
- 批准号:
16K10698 - 财政年份:2016
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of Human Lymphoid Chromosomal Translocation
人类淋巴染色体易位的机制
- 批准号:
10219165 - 财政年份:2016
- 资助金额:
$ 4.48万 - 项目类别:
Mechanisms of Human Lymphoid Chromosomal Translocation
人类淋巴染色体易位的机制
- 批准号:
9756315 - 财政年份:2016
- 资助金额:
$ 4.48万 - 项目类别:
Mechanisms of Human Lymphoid Chromosomal Translocation
人类淋巴染色体易位的机制
- 批准号:
9099617 - 财政年份:2016
- 资助金额:
$ 4.48万 - 项目类别:
Proof of mutual interference between two DNA double strand break sites leading to chromosomal translocation
两个 DNA 双链断裂位点之间相互干扰导致染色体易位的证据
- 批准号:
15H02816 - 财政年份:2015
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of DNA repair imbalance in chromosomal translocation in sarcomas
DNA 修复失衡在肉瘤染色体易位中的作用
- 批准号:
15K10451 - 财政年份:2015
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




